Sign up to save your podcasts
Or
Share Episode: 48 - A Conversation with Peter Tessier: Classifying Antibodies to Assess Biologics Developability Features Early in the Discovery Process
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode: 48 - A Conversation with Peter Tessier: Classifying Antibodies to Assess Biologics Developability Features Early in the Discovery Process
In this month’s episode of the Chain, guest Peter Tessier, Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the University of Michigan, speaks with moderator Tariq Ghayur, scientific advisor and entrepreneur in residence at FairJourney Biologics, about expediting the developability of antibodies. He discusses the characteristics that best predict a molecule’s drug-like properties, the different assays used for various intended outcomes, and why every scientist must assess the “greatest potential impact” before embarking on a new experiment. Tessier also talks about the core traditions that help him lead students in the lab while fostering a learning environment of ownership, integrity, and self-motivation. Last, he shares his predictions on how computational data will advance antibody discovery and developability in the future.
View all episodes
By Cambridge Healthtech Institute
4.8
2525 ratings
In this month’s episode of the Chain, guest Peter Tessier, Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the University of Michigan, speaks with moderator Tariq Ghayur, scientific advisor and entrepreneur in residence at FairJourney Biologics, about expediting the developability of antibodies. He discusses the characteristics that best predict a molecule’s drug-like properties, the different assays used for various intended outcomes, and why every scientist must assess the “greatest potential impact” before embarking on a new experiment. Tessier also talks about the core traditions that help him lead students in the lab while fostering a learning environment of ownership, integrity, and self-motivation. Last, he shares his predictions on how computational data will advance antibody discovery and developability in the future.
More shows like The Chain: Protein Engineering Podcast
View all
Nature Podcast
757 Listeners
Planet Money
30,898 Listeners
StarTalk Radio
14,115 Listeners
Hidden Brain
43,390 Listeners
Pivot
9,120 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,307 Listeners
The Long Run with Luke Timmerman
122 Listeners
The Readout Loud
316 Listeners
Think Fast Talk Smart: Communication Techniques
798 Listeners
Business Of Biotech
87 Listeners
BioCentury This Week
30 Listeners
Hard Fork
5,422 Listeners
Biotech Hangout
9 Listeners
The Joy of Why
498 Listeners
Prof G Markets
1,035 Listeners